Cargando…
Irisin is a predictor of sarcopenic obesity in type 2 diabetes mellitus: A cross-sectional study
We aimed to evaluate sarcopenia and sarcopenic obesity (SO) in patients with type 2 diabetes mellitus (T2DM), possible relationships with serum irisin and myostatin levels, and the effect of glycemic control on SO. Ninety T2DM patients were included in this a cross-sectional study. Sarcopenia was de...
Autores principales: | Oguz, Ayten, Sahin, Murat, Tuzun, Dilek, Kurutas, Ergul B., Ulgen, Cansu, Bozkus, Ozlem, Gul, Kamile |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257893/ https://www.ncbi.nlm.nih.gov/pubmed/34190188 http://dx.doi.org/10.1097/MD.0000000000026529 |
Ejemplares similares
-
Is FGF-23 an early indicator of atherosclerosis and cardiac dysfunction in patients with gestational diabetes?
por: Tuzun, Dilek, et al.
Publicado: (2018) -
High Serum Irisin Level as an Independent Predictor of Diabetes Mellitus: A Longitudinal Population-Based Study
por: Huh, Ji Hye, et al.
Publicado: (2016) -
Primary Adrenal Failure due to Antiphospholipid Syndrome
por: Sahin, Murat, et al.
Publicado: (2015) -
Does insulin resistance increase thyroid volume in patients with polycystic ovary syndrome?
por: Sahin, Murat, et al.
Publicado: (2016) -
Assessment of Subclinical Cardiac Alterations and Atrial
Electromechanical Delay by Tissue Doppler Echocardiography in Patients with
Nonfunctioning Adrenal Incidentaloma
por: Sokmen, Gulizar, et al.
Publicado: (2018)